James Neal

Insider Reports History

Location
2910 Seventh Street, Berkeley, CA
Signature
/s/ James Neal by John J. Wolfel, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Neal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
XOMA Corp CEO, Director 8.625% Series A Cumulative Perpetual Preferred Stock 8K $205K $25.60 Jul 15, 2022 By spouse
XOMA Corp CEO, Director Depositary Shares - 8.375% B Cumulative Stock 8K $190K $23.79 Jul 15, 2022 By spouse
XOMA Corp CEO, Director Common Stock 11.8K $164K $13.89 Jul 15, 2022 Direct
XOMA Corp CEO, Director Common Stock 5.56K $77.2K $13.89 Jul 15, 2022 By 401(k) Plan
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 36.3K $40.6K $1.12 Mar 20, 2025 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 32.2M $19.3K $0.00 Jan 9, 2025 Direct
Akari Therapeutics Plc Director Series A Warrants (Right to Buy) 4.46K $5K $1.12 Mar 6, 2025 Direct
Akari Therapeutics Plc Director Series B Warrants (Right to Buy) 4.46K $5K $1.12 Mar 6, 2025 Direct
PALISADE BIO, INC. Director Common Stock, par value $0.01 10.9K $4.76K $0.44 Feb 9, 2024 Direct
PALISADE BIO, INC. Director Restricted Stock Units 0 $0 $0.44 Feb 9, 2024 Direct
Peak Bio, Inc. Director Common Stock 0 $0 $0.27 Nov 14, 2024 Direct
Processa Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 300K Oct 1, 2025 Direct
Akari Therapeutics Plc Director Stock Option (Right to Buy) 225K Mar 20, 2025 Direct
XOMA Corp CEO, Director Stock Option (Right to Buy) 218K Jul 15, 2022 Direct
Processa Pharmaceuticals, Inc. Director Restricted Stock 207K Jul 24, 2025 Direct
Processa Pharmaceuticals, Inc. Director Restricted Stock Units 100K Oct 1, 2025 Direct
XOMA Corp CEO, Director Non-Qualified Share Option (right to buy) 60K Dec 21, 2021 Direct
Monterey Bio Acquisition Corp Director Common Stock 35K Sep 30, 2021 Direct
PALISADE BIO, INC. Director Common Stock Options 6.88K Feb 9, 2024 Direct
Peak Bio, Inc. Director Convertible Notes 0 Nov 14, 2024 Direct
Peak Bio, Inc. Director Stock Option (Right to Buy) 0 Nov 14, 2024 Direct
Peak Bio, Inc. Director Warrant (Right to Purchase) 0 Nov 14, 2024 Direct

Insider Reports Filed by James Neal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCSA Processa Pharmaceuticals, Inc. Oct 1, 2025 2 $0 4 Oct 3, 2025 Director
PCSA Processa Pharmaceuticals, Inc. Jul 24, 2025 1 $0 4/A Sep 18, 2025 Director
AKTX Akari Therapeutics Plc Mar 20, 2025 2 $0 4 Mar 24, 2025 Director
AKTX Akari Therapeutics Plc Mar 6, 2025 3 $15K 4 Mar 10, 2025 Director
AKTX Akari Therapeutics Plc Jan 9, 2025 1 $4.8K 4 Jan 10, 2025 Director
AKTX Akari Therapeutics Plc Dec 23, 2024 1 $1K 4 Dec 26, 2024 Director
AKTX Akari Therapeutics Plc Nov 14, 2024 0 $0 3 Nov 22, 2024 Director
PKBO Peak Bio, Inc. Nov 14, 2024 5 -$20K 4 Nov 18, 2024 Director
PCSA Processa Pharmaceuticals, Inc. Sep 3, 2024 1 $0 4 Sep 18, 2024 Director
PALI PALISADE BIO, INC. Feb 9, 2024 8 $0 4 Feb 13, 2024 Director
PALI PALISADE BIO, INC. Nov 21, 2023 2 $0 4 Nov 24, 2023 Director
PCSA Processa Pharmaceuticals, Inc. Jun 27, 2023 3 $0 4 Jul 24, 2023 Director
PALI PALISADE BIO, INC. Jun 11, 2023 2 $0 4 Jun 13, 2023 Director
PKBO Peak Bio, Inc. Apr 28, 2023 2 $20K 4 May 2, 2023 Director
PKBO Peak Bio, Inc. Nov 1, 2022 0 $0 3 Nov 3, 2022 Director
PCSA Processa Pharmaceuticals, Inc. Jul 19, 2022 1 $0 4 Jul 21, 2022 Director
PCSA Processa Pharmaceuticals, Inc. Jul 19, 2022 0 $0 3 Jul 21, 2022 Director
XOMA XOMA Corp Jul 15, 2022 5 -$645K 4 Jul 18, 2022 CEO, Director
XOMA XOMA Corp Mar 21, 2022 9 -$1.34M 4 Mar 23, 2022 CEO, Director
XOMA XOMA Corp Dec 21, 2021 1 $0 4 Dec 23, 2021 CEO, Director
PALI PALISADE BIO, INC. Nov 18, 2021 1 $0 4 Feb 10, 2022 Director
MTRY Monterey Bio Acquisition Corp Sep 30, 2021 0 $0 3 Sep 30, 2021 Director
XOMA XOMA Corp Jun 25, 2021 3 -$303K 4 Jun 29, 2021 CEO, Director